Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs

Advances in Protein Chemistry and Structural Biology

Volumn 98, Issue , 2015, Pages 169-221

  Elzoghby, Ahmed O ^a   Elgohary, Mayada M ^a   Kamel, Nayra M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ELASTIN; GELATIN; GLIADIN; LYSOZYME; MILK PROTEIN; NANOCARRIER; PEPTIDE; PEPTIDE NANOPARTICLE; POLYELECTROLYTE; PROTAMINE; PROTEIN; PROTEIN NANOPARTICLE; SILK PROTEIN; UNCLASSIFIED DRUG; ZEIN; ALBUMINOID; NANOPARTICLE;

ARTICLE; CANCER THERAPY; COACERVATION; COMPLEX FORMATION; CONJUGATION; CROSS LINKING; DESOLVATION; ELECTROSPRAY; EMULSION; EVAPORATION; GLYCATION; NANOTECHNOLOGY; PHASE SEPARATION; PRECIPITATION; PRIORITY JOURNAL; SPRAY DRYING; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; GENETICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PROCEDURES; STATIC ELECTRICITY; ULTRASTRUCTURE;

ALBUMINS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; ELASTIN; GELATIN; GLIADIN; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MILK PROTEINS; MOLECULAR TARGETED THERAPY; MURAMIDASE; NANOPARTICLES; NEOPLASMS; STATIC ELECTRICITY; ZEIN;

EID: 84938073327     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2014.12.002     Document Type: Chapter

References (145)

1. Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., et al. (2003). Silkbased biomaterials. Biomaterials, 24, 401-416.
2. Anhorn, M., Mahler, H., and Langer, K. (2008). Freeze-drying of human serum albumin (HSA) nanoparticles with different excipients. International Journal of Pharmaceutics, 363(1-2), 162-169.
3. Bachar, M., Mandelbaum, A., Portnaya, I., Perlstein, H., Even-Chen, S., and Barenholz, Y. (2012). Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles. Journal of Controlled Release, 160, 164-171.
4. Bae, S., Ma, K., Kim, T. H., Lee, E. S., Oh, K. T., Park, E. S., et al. (2012). Doxorubicinloaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. Biomaterials, 33(5), 1536-1546.
5. Bajpai, A. K., and Choubey, J. (2006). In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticles. Journal of Applied Polymer Science, 101, 2320-2332.
6. Bertrand, N., Wu, J., Xu, X., Kamaly, N., and Farokhzad, O. C. (2014). Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews, 66, 2-25.
7. Bidwell, G. L., III, Davis, A. N., Fokt, I., Priebe, W., and Raucher, D. (2007). A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Investigational New Drugs, 25, 313-326.
8. Burger, A., Hartung, G., Stehle, G., Sinn, H., and Fiebig, H. (2001). Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo. International Journal of Cancer, 92(5), 718-724.
9. Callahan, D. J., Liu, W., Li, X., Dreher, M. R., Hassouneh, W., Kim, M., et al. (2012). Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution. Nano Letters, 12(4), 2165-2170.
10. Cascone, M. G., Lazzeri, L., Carmignani, C., and Zhu, Z. (2002). Gelatin nanoparticles prepared by a simple w/o emulsion as delivery system for methotrexate. Journal of Materials Science. Materials in Medicine, 13(5), 523-526.
11. Chen, D., Tang, Q., Xue, W., Xiang, J., Zhang, L., and Wang, X. (2010). The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles. Journal of Biomedical Research, 24(1), 26-32.
12. Chen, Y., Youn, P., and Furgeson, D. Y. (2011). Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers. Journal of Controlled Release, 155(2), 175-183.
13. Cheng, Z., Dai, Y., Kang, X., Li, C., Huang, S., Lian, H., et al. (2014). Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI. Biomaterials, 35, 6359-6368.
14. Cheng, H., Li, Y. Y., Zeng, X., Sun, Y. X., Zhang, X. Z., and Zhuo, R. X. (2009). Protamine sulfate/poly(L-aspartic acid) polyionic complexes self-assembled via electrostatic attractions for combined delivery of drug and gene. Biomaterials, 30(6), 1246-1253.
15. Choubey, J., and Bajpai, A. K. (2010). Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. Journal of Materials Science. Materials in Medicine, 21, 1573-1586.
16. Coester, C. J., Langer, K., van Briesen, H., and Kreuter, J. (2000). Gelatin nanoparticles by two-step desolvation-A new preparation method, surface modification and cell uptake. Journal of Microencapsulation, 17, 187-193.
17. Cui, M., Naczynski, D., Zevon, M., Griffith, C., Sheihet, L., Poventud-Fuentes, I., et al. (2013). Multifunctional albumin nanoparticles as combination drug carriers for intratumoral chemotherapy. Advanced Healthcare Materials, 2(9), 1236-1245.
18. Desai, N. (2007). Nanoparticle albumin bound (nab) technology: Targeting tumors through the endothelial gp60 receptor and SPARC. Nanomedicine, 3, 337-346.
19. Ding, D., Zhu, Z., Li, R., Li, X., Wu, W., Jiang, X., et al. (2011). Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. ACS Nano, 5, 2520-2534.
20. Dreher, M. R., Raucher, D., Balu, N., Michael, C. O., Ludeman, S. M., and Chilkoti, A. (2003). Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy. Journal of Controlled Release, 91(1-2), 31-43.
21. Dreher, M. R., Simnick, A. J., Fischer, K., Smith, R. J., Patel, A., Schmidt, M., et al. (2008). Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. Journal of the American Chemical Society, 130, 687-694.
22. Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., and Langer, K. (2007). Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics, 341(1-2), 207-214.
23. Dubey, P., Singodia, D., Verma, R., and Vyas, S. (2010). RGD modified albumin nanospheres for tumour vasculature targeting. The Journal of Pharmacy and Pharmacology, 63(1), 33-40.
24. Egusquiaguirre, S. P., Igartua, M., Hernandez, R. M., and Pedraz, J. L. (2012). Nanoparticle delivery systems for cancer therapy: Advances in clinical and preclinical research. Clinical and Translational Oncology, 14(2), 83-93.
25. Elgindy, N., Elkhodairy, K., Molokhia, A., and Elzoghby, A. (2010). Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide. European Journal of Pharmaceutics and Biopharmaceutics, 74, 397-405.
26. Elgindy, N., Elkhodairy, K., Molokhia, A., and Elzoghby, A. (2011a). Biopolymeric microparticles combined with lyophilized monophase dispersions for controlled flutamide release. International Journal of Pharmaceutics, 411, 113-120.
27. Elgindy, N., Elkhodairy, K., Molokhia, A., and Elzoghby, A. (2011b). Biopolymeric nanoparticles for oral protein delivery: Design and in vitro evaluation. Journal of Nanomedicine and Nanotechnology, 2, 1-8.
28. Elgindy, N., Elkhodairy, K., Molokhia, A., and Elzoghby, A. (2011c). Lyophilization monophase solution technique for preparation of amorphous flutamide dispersions. Drug Development and Industrial Pharmacy, 37, 754-764.
29. Elgindy, N., Elkhodairy, K., Molokhia, A., and Elzoghby, A. (2011d). Lyophilized flutamide dispersions with polyols and amino acids: Preparation and in vitro evaluation. Drug Development and Industrial Pharmacy, 37, 446-455.
30. Elgindy, N. A., Samy, W. A., and Elzoghby, A. O. (2014). Casein-based micelles: A novel vector for delivery of the poorly soluble anticancer drug, flutamide? Therapeutic Delivery, 5, 7-9.
31. Elsadek, B., and Kratz, F. (2012). Impact of albumin on drug delivery-New applications on the horizon. Journal of Controlled Release, 157(1), 4-28.
32. Elzoghby, A. O. (2013). Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. Journal of Controlled Release, 172, 1075-1091.
33. Elzoghby, A. O., Abo El-Fotoh, W. S., and Elgindy, N. A. (2011). Casein-based formulations as promising controlled release drug delivery systems. Journal of Controlled Release, 153, 206-216.
34. Elzoghby, A. O., Helmy, M. W., Samy, W. M., and Elgindy, N. A. (2013a). Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgendependent prostate cancer rat model. Pharmaceutical Research, 30, 2654-2663.
35. Elzoghby, A. O., Helmy, M. W., Samy, W. M., and Elgindy, N. A. (2013b). Novel ionically crosslinked casein nanoparticles for flutamide delivery: Formulation, characterization, and in vivo pharmacokinetics. International Journal of Nanomedicine, 8, 1721.
36. Elzoghby, A. O., Helmy, M. W., Samy, W. M., and Elgindy, N. A. (2013c). Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics, 84, 487-496.
37. Elzoghby, A. O., Saad, N. I., Helmy, M. W., Samy, W. M., and Elgindy, N. A. (2013). Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats. European Journal of Pharmaceutics and Biopharmaceutics, 85, 444-451.
38. Elzoghby, A. O., Samy, W. M., and Elgindy, N. A. (2012a). Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release, 157, 168-182.
39. Elzoghby, A. O., Samy, W. M., and Elgindy, N. A. (2012b). Protein-based nanocarriers as promising drug and gene delivery systems. Journal of Controlled Release, 161, 38-49.
40. Elzoghby, A. O., Samy, W. M., and Elgindy, N. A. (2013). Novel spray-dried genipincrosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride. Pharmaceutical Research, 30, 512-522.
41. Esmaili, M., Ghaffari, S. M., Moosavi-Movahedi, Z., Atri, M. S., Sharifizadeh, A., and Farhadi, M. (2011). Beta casein-micelle as a nanovehicle for solubility enhancement of curcumin; food industry application. LWT-Food Science and Technology, 44, 2166-2172.
42. Furgeson, D. Y., Dreher, M. R., and Chilkoti, A. (2006). Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors. Journal of Controlled Release, 110(2), 362-369.
43. Gaowa, A., Horibe, T., Kohno, M., Sato, K., Harada, H., Hiraoka, M., et al. (2014). Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo. Journal of Controlled Release, 176, 1-7.
44. Garga, M., Madan, J., Pandey, R. S., Sardana, S., Katyal, A., and Chandra, R. (2012). Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells. Anti-Cancer Drugs, 23, 836-845.
45. Ghalandari, B., Divsalar, A., Saboury, A. A., and Parivar, K. (2014). The new insight into oral drug delivery system based on metal drugs in colon cancer therapy through b-lactoglobulin/oxali-palladium nanocapsules. Journal of Photochemistry and Photobiology B: Biology, 140, 255-265.
46. Girard, M., Turgeon, S. L., and Gauthier, S. F. (2002). Interbiopolymer complexing between β-lactoglobulin and low- and high-methoxylated pectin measured by potentiometric titration and ultrafiltration. Food Hydrocolloids, 16, 585-591.
47. Golla, K., Bhaskar, C., Ahmed, F., and Kondapi, A. K. (2013). A target-specific oral formulation of doxorubicin-protein nanoparticles: Efficacy and safety in hepatocellular cancer. Journal of Cancer, 4, 644-652.
48. Golla, K., Cherukuvada, B., Ahmed, F., and Kondapi, A. K. (2012). Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS One, 7, e51960.
49. Gong, J., Huo, M., Zhou, J., Zhang, Y., Peng, X., Yu, D., et al. (2009). Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles. International Journal of Pharmaceutics, 376(1-2), 161-168.
50. Gulfam, M., Kim, J. E., Lee, J. M., Ku, B., Chung, B. H., and Chung, B. G. (2012). Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells. Langmuir, 28, 8216-8223.
51. Guo, R., Cheng, Y., Ding, D., Li, X., Zhang, L., Jiang, X., et al. (2011). Synthesis and antitumoral activity of gelatin/polyoxometalate hybrid nanoparticles. Macromolecular Bioscience, 11, 839-847.
52. Gupta, V., Aseh, A., Rios, C. N., Aggarwal, B. B., and Mathur, A. B. (2009). Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. International Journal of Nanomedicine, 4, 115-122.
53. Gustafson, J. A., and Ghandehari, H. (2010). Silk-elastin like protein polymers for matrixmediated cancer gene therapy. Advanced Drug Delivery Reviews, 62(15), 1509-1523.
54. Han, S., Li, M., Liu, X., Gao, H., and Wu, Y. (2013). Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery. Colloids and Surfaces B: Biointerfaces, 102, 833-841.
55. Hao, H., Ma, Q., Huang, C., He, F., and Yao, P. (2013). Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface. International Journal of Pharmaceutics, 444(1-2), 77-84.
56. Hawkins, M. J., Soon-Shiong, P., and Desai, N. (2008). Protein nanoparticles as drug carriers in clinical medicine. Advanced Drug Delivery Reviews, 60(8), 876-885.
57. Hu, D., Lin, C., Liu, L., Li, S., and Zhao, Y. (2012). Preparation, characterization, and in vitro release investigation of lutein/zein nanoparticles via solution enhanced dispersion by supercritical fluids. Journal of Food Engineering, 109, 545-552.
58. Jain, A., Gulbake, A., Jain, A., Shilpi, S., Hurkat, P., Jain, A., et al. (2012). Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumor targeting. Journal of Microencapsulation, 29, 95-102.
59. Jiang, H. R., and Liu, N. (2010). Self-assembled β-lactoglobulin-conjugated linoleic acid complex for colon cancer-targeted substance. Journal of Dairy Science, 93, 3931-3939.
60. Karmali, P., Kotamraju, V., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., et al. (2009). Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Journal of Nanomedicine and Nanotechnology, 5(1), 73-82.
61. Karthikeyan, S., Prasad, N. R., Ganamani, A., and Balamurugan, E. (2013). Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells. Biomedicine and Preventive Nutrition, 3, 64-73.
62. Kaul, G., and Amiji, M. (2005). Tumor-targeted gene delivery using poly(ethylene glycol)- modified gelatin nanoparticles: In vitro and in vivo studies. Pharmaceutical Research, 22, 951-961.
63. Kim, T. H., Jiang, H. H., Youn, Y. S., Park, C. W., Tak, K. K., Lee, S., et al. (2011). Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. International Journal of Pharmaceutics, 403, 285-291.
64. Kommareddy, S., and Amiji, M. (2005). Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjugate Chemistry, 16, 1423-1432.
65. Kommareddy, S., and Amiji, M. (2007). Poly (ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine, 3, 32-42.
66. Kouchakzadeh, H., Shojaosadati, S., Maghsoudi, A., and Farahani, E. (2010). Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology. AAPS PharmSciTech, 11(3), 1206-1211.
67. Kratz, F. (2014). A clinical update of using albumin as a drug vehicle-A commentary. Journal of Controlled Release, 190, 331-336.
68. Lai, L. F., and Guo, H. X. (2011). Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. International Journal of Pharmaceutics, 404, 317-323.
69. Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., and Schubert, D. (2003). Optimization of the preparation process for human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics, 257, 169-180.
70. Lee, J., Bae, K., Kim, J., Nam, Y., and Park, T. (2011). Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA-Multi-armed PEG nanocapsules. Biomaterials, 32(33), 8635-8644.
71. Lee, S. H., Heng, D., Ng, W. K., Chan, H. K., and Tan, R. B. (2011). Nano spray drying: A novel method for preparing protein nanoparticles for protein therapy. International Journal of Pharmaceutics, 403, 192-200.
72. Lee, E. J., Khan, S. A., Park, J. K., and Lim, K. H. (2012). Studies on the characteristics of drugloaded gelatin nanoparticles prepared by nanoprecipitation. Bioprocess and Biosystems Engineering, 35, 297-307.
73. Lee, G. Y., Park, K., Nam, J. H., Kim, S. Y., and Byun, Y. (2006). Anti-tumor and antimetastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice. Journal of Drug Targeting, 14, 707-716.
74. Lee, S. J., Yhee, J. Y., Kim, S. H., Kwon, I. C., and Kim, K. (2013). Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice. Journal of Controlled Release, 172(1), 358-366.
75. Leo, E., Vandelli, M. A., Cameroni, R., and Forni, F. (1997). Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde involvement of the drug in the cross-linking process. International Journal of Pharmaceutics, 155, 75-82.
76. Li, W., Liu, D., and Chen, S. (2011). Amphiphilically-modified gelatin nanoparticles: Selfassembly behavior, controlled biodegradability, and rapid cellular uptake for intracellular drug delivery. Journal of Materials Chemistry, 21, 12381-12388.
77. Li, Q., Liu, C., Zhao, X., Zu, Y., Wang, Y., Zhang, B., et al. (2011). Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folateconjugated human serum albumin nanoparticles to cancer cells. International Journal of Nanomedicine, 6, 397-405.
78. Liang, L., Tajmir-Riahi, H. A., and Subirade, M. (2008). Interaction of beta-lactoglobulin with resveratrol and its biological implications. Biomacromolecules, 9, 50-56.
79. Liu, W., MacKay, J. A., Dreher, M. R., Chen, M., McDaniel, J. R., Simnick, A. J., et al. (2010). Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model. Journal of Controlled Release, 144(1), 2-9.
80. Liu, W., McDaniel, J., Li, X., Asai, D., Quiroz, F. G., Schaal, J., et al. (2012). Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ. Cancer Research, 72(22), 5956-5965.
81. Livney, Y. D. (2010). Milk proteins as vehicles for bioactives. Current Opinion in Colloid and Interface Science, 15, 73-83.
82. Lu, Z., Yeh, T. K., Tsai, M., Au, J. L., and Wientjes, M. G. (2004). Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clinical Cancer Research, 10(22), 7677-7684.
83. MacEwan, S. R., and Chilkoti, A. (2014). Applications of elastin-like polypeptides in drug delivery. Journal of Controlled Release, 190, 314-330.
84. MacKay, J. A., Chen, M., McDaniel, J. R., Liu, W., Simnick, A. J., and Chilkoti, A. (2009). Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumors after a single injection. Nature Materials, 8(12), 993-999.
85. Madan, J., Dhiman, N., Sardana, S., Aneja, R., Chandra, R., and Katyal, A. (2011). Long-circulating poly (ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses. Anti-Cancer Drugs, 22, 543-555.
86. Maghsoudi, A., Shojaosadati, S., and Farahani, E. (2008). 5-Fluorouracil-loaded BSA nanoparticles: Formulation optimization and in vitro release study. AAPS PharmSciTech, 9(4), 1092-1096.
87. Maham, A., Tang, Z., Wu, H., Wang, J., and Lin, Y. (2009). Protein-based nanomedicine platforms for drug delivery. Small, 5(15), 1706-1721.
88. Mandal, B. B., and Kundu, S. C. (2009). Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery. Nanotechnology, 20(35), 355101.
89. Martinez, A., Muniz, E., Iglesias, I., Teijon, J., and Blanco, M. (2012). Enhanced preclinical efficacy of tamoxifen developed as alginate-cysteine/disulfide bond reduced albumin nanoparticles. International Journal of Pharmaceutics, 436(1-2), 574-581.
90. Massodi, I., Bidwell, G. L., III, and Raucher, D. (2005). Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. Journal of Controlled Release, 108, 396-408.
91. McDaniel, J. R., Callahan, D. J., and Chilkoti, A. (2010). Drug delivery to solid tumors by elastin-like polypeptides. Advanced Drug Delivery Reviews, 62, 1456-1467.
92. McDaniel, J. R., MacEwan, S. R., Li, X., Radford, D. C., Landon, C. D., Dewhirst, M., et al. (2014). Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors. Nano Letters, 14(5), 2890-2895.
93. Mimi, H., Ho, K. M., Siu, Y. S., Wu, A., and Li, P. (2012). Polyethyleneimine-based core- shell nanogels: A promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in Hela cells. Journal of Controlled Release, 158, 123-130.
94. Narayanan, S., Pavithran, M., Viswanath, A., Narayanan, D., Mohan, C. C., Manzoor, K., et al. (2014). Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: Design, synthesis, biocompatibility and pharmacokinetics. Acta Biomaterialia, 10, 2112-2124.
95. Numata, K., and Kaplan, D. L. (2010). Silk-based delivery systems of bioactive molecules. Advanced Drug Delivery Reviews, 62, 1497-1508.
96. Pan, K., Zhong, Q., and Baek, S. J. (2013). Enhanced dispersibility and bioactivity of curcumin by encapsulation in casein nanocapsules. Journal of Agricultural and Food Chemistry, 61, 6036-6043.
97. Patel, A. R., Heussen, P. C. M., Hazekamp, J., Drost, E., and Velikov, K. P. (2012). Quercetin loaded biopolymeric colloidal particles prepared by simultaneous precipitation of quercetin with hydrophobic protein in aqueous medium. Food Chemistry, 133, 423-429.
98. Patel, A., Hu, Y., Tiwari, J. K., and Velikov, K. P. (2010). Synthesis and characterization of zein-curcumin colloidal particles. Soft Matter, 6, 6192-6199.
99. Pereverzeva, E., Treschalin, I., Bodyagin, D., Maksimenko, O., Langer, K., Dreis, S., et al. (2007). Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity. International Journal of Pharmaceutics, 337(1-2), 346-356.
100. Podaralla, S., Averineni, R., Alqahtani, M., and Perumal, O. (2012). Synthesis of novel biodegradable methoxypoly(ethylene glycol)-zein micelles for effective delivery of curcumin. Molecular Pharmaceutics, 9, 2778-2786.
101. Qi, J., Yao, P., He, F., Yu, C., and Huang, C. (2010). Nanoparticles with dextran/chitosan shell and BSA/chitosan core-Doxorubicin loading and delivery. International Journal of Pharmaceutics, 393(1-2), 176-184.
102. Razmi, M., Divsalar, A., Saboury, A. A., Izadi, Z., Haertle, T., and Mansuri-Torshizi, H. (2013). Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug. Colloids and Surfaces B: Biointerfaces, 112, 362-367.
103. Sebak, S., Mirzaei, M., Malhotra, M., Kulamarva, A., and Prakash, S. (2010). Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: Preparation and in vitro analysis. International Journal of Nanomedicine, 5, 525-532.
104. Seib, F. P., Jones, G. T., Rnjak-Kovacina, J., Lin, Y., and Kaplan, D. L. (2013). pH-dependent anticancer drug release from silk nanoparticles. Advanced Healthcare Materials, 2(12), 1606-1611.
105. Shapira, A., Assaraf, Y. G., Epstein, D., and Livney, Y. D. (2010). Beta-casein nanoparticles as an oral delivery system for chemotherapeutic drugs: Impact of drug structure and properties on co-assembly. Pharmaceutical Research, 27, 2175-2186.
106. Shapira, A., Assaraf, Y. G., and Livney, Y. D. (2010). Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs. Nanomedicine, 6, 119-126.
107. Shapira, A., Davidson, I., Avni, N., Assaraf, Y. G., and Livney, Y. D. (2012). β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: Stability, target-activated release and cytotoxicity. European Journal of Pharmaceutics and Biopharmaceutics, 80, 298-305.
108. Shapira, A., Markman, G., Assaraf, Y. G., and Livney, Y. D. (2010). β-Casein-based nanovehicles for oral delivery of chemotherapeutic drugs: Drug-protein interactions and mitoxantrone loading capacity. Nanomedicine, 6, 547-555.
109. Shen, Z., Wei, W., Zhao, Y., Ma, G., Dobashi, T., Maki, Y., et al. (2008). Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. European Journal of Pharmaceutical Sciences, 35(4), 271-282.
110. Shi, P., Aluri, S., Lin, Y. A., Shah, M., Edman, M., Dhandhukia, J., et al. (2013). Elastinbased protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. Journal of Controlled Release, 171, 330-338.
111. Shpigelman, A., Israeli, G., and Livney, Y. D. (2010). Thermally-induced protein polyphenol co-assemblies: Betalactoglobulin-based nanocomplexes as protective nanovehicles for EGCG. Food Hydrocolloids, 24, 735-743.
112. Shutava, T. G., Balkundi, S. S., Vangala, P., Steffan, J. J., Bigelow, R. L., Cardelli, J. A., et al. (2009). Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano, 3, 1877-1885.
113. Sneharani, A. H., Karakkat, J. V., Singh, S. A., and Rao, A. G. A. (2010). Interaction of curcumin with β-lactoglobulin; stability, spectroscopic analysis, and molecular modeling of the complex. Journal of Agricultural and Food Chemistry, 58, 11130-11139.
114. Son, S., Song, S., Lee, S. J., Min, S., Kim, S. A., Yhee, J. Y., et al. (2013). Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors. Biomaterials, 34(37), 9475-9485.
115. Steinhauser, I., Langer, K., Strebhardt, K., and Spankuch, B. (2008). Effect of trastuzumabmodified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation. Biomaterials, 29(29), 4022-4028.
116. Su, Z., Xing, L., Chen, Y., Xu, Y., Yang, F., Zhang, C., et al. (2014). Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Molecular Pharmaceutics, 11(6), 1823-1834.
117. Sun, Q.,Teong, B.,Chen, I.,Chang, S. J., Gao, J.,and Kuo, S. (2014). Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells. Journal of BiomedicalMaterials Research Part B: Applied Biomaterials, 102B, 455-462.
118. Taheri, A., Atyabi, F., Nouri, F. S., Ahadi, F., Derakhshan, M., Amini, M., et al. (2011). Nanoparticles of conjugated methotrexate-human serum albumin: Preparation and cytotoxicity evaluations. Journal of Nanomaterials, 2011, 1-7.
119. Taheri, A., Dinarvand, R., Ahadi, F., Khorramizadeh, M., and Atyabi, F. (2012). The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice. International Journal of Pharmaceutics, 431(1-2), 183-189.
120. Taheri, A., Dinarvand, R., Atyabi, F., Ghahremani, M., and Ostad, S. (2012). Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells. European Journal of Pharmaceutical Sciences, 47(2), 331-340.
121. Taheri, A., Dinarvand, R., Nouri, F. S., Khorramizadeh, M. R., Borougeni, A. T., Mansoori, P., et al. (2011). Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy. International Journal of Nanomedicine, 6, 1863-1874.
122. Tseng, C., Su, W., Yen, K., Yang, K., and Lin, F. (2009). The use of biotinylated-EGFmodified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials, 30, 3476-3485.
123. van Bracht, E., Stolle, S., Hafmans, T. G., Boerman, O. C., Oosterwijk, E., van Kuppevelt, T. H., et al. (2014). Specific targeting of tumor cells by lyophilisomes functionalized with antibodies. European Journal of Pharmaceutics and Biopharmaceutics, 87(1), 80-89.
124. Varshosaz, J., Hassanzadeh, F., Sadeghi, H., Ghelich Khan, Z., and Rostami, M. (2013). Retinoic acid decorated albumin-chitosan nanoparticles for targeted delivery of doxorubicin hydrochloride in hepatocellular carcinoma. Journal of Nanomaterials, 2013, 1-12.
125. Wagner, S., Rothweiler, F., Anhorn, M., Sauer, D., Riemann, I., Weiss, E., et al. (2010). Enhanced drug targeting by attachment of an anti ?v integrin antibody to doxorubicin loaded human serum albumin nanoparticles. Biomaterials, 31(8), 2388-2398.
126. Won, Y., Yoon, S., Sonn, C. H., Lee, K., and Kim, Y. (2011). Nano self-assembly of recombinant human gelatin conjugated with ?-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery. ACS Nano, 5, 3839-3848.
127. Wu, D. C., Cammarata, C. R., Park, H. J., Rhodes, B. T., and Ofner, C. M. (2013). Preparation, drug release, and cell growth inhibition of a gelatin-doxorubicin conjugate. Pharmaceutical Research, 30, 2087-2096.
128. Xia, X. X., Wang, M., Lin, Y., Xu, Q., and Kaplan, D. L. (2014). Hydrophobic drug-triggered self-assembly of nanoparticles from silk-elastin-like protein polymers for drug delivery. Biomacromolecules, 15(3), 908-914.
129. Xie, J., Marijnissen, J. C., and Wang, C. H. (2006). Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. Biomaterials, 27, 3321-3332.
130. Xu, J., Singh, A., and Amiji, M. M. (2014). Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer. BMC Cancer, 14(75), 1-12.
131. Xue, J., Tan, C., Zhang, X., Feng, B., and Xia, S. (2014). Fabrication of epigallocatechin-3- gallate nanocarrier based on glycosylated casein: Stability and interaction mechanism. Journal of Agricultural and Food Chemistry, 62, 4677-4684.
132. Yang, L., Cui, F., Cun, D. M., Tao, A., Shi, K., and Lin, W. H. (2007). Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. International Journal of Pharmaceutics, 340, 163-172.
133. Yeh, T. K., Lu, Z., Wientjes, M. G., and Au, J. L. S. (2005). Formulating paclitaxel in nanoparticles alters its disposition. Pharmaceutical Research, 22(6), 867-874.
134. Yi, Y. M., Yang, T. Y., and Pan, W. M. (1999). Preparation and distribution of 5-fluorouracil (125)I sodium alginate-bovine serum albumin nanoparticles. World Journal of Gastroenterology, 5(1), 57-60.
135. Zhang, Z. H., Wang, X. P., Ayman, W. Y., Munyendo, W. L., Lv, H. X., and Zhou, J. P. (2013). Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Delivery, 20, 86-93.
136. Zhang, L., Zhang, S., Ruan, S. B., Zhang, Q. Y., He, Q., and Gao, H. L. (2014). Lapatinibincorporated lipoprotein-like nanoparticles: Preparation and a proposed breast cancertargeting mechanism. Acta Pharmacologica Sinica, 35(6), 846-852.
137. Zhao, D., Zhao, X., Zu, Y., Li, J., Zahng, Y., Jiang, R., et al. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. International Journal of Nanomedicine, 5, 1-9.
138. Zhen, X., Wang, X., Xie, C., Wu, W., and Jiang, X. (2013). Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials, 34(4), 1372-1382.
139. Zhou, H., Sun, X., Zhang, L., Zhang, P., Li, J., and Liu, Y. (2012). Fabrication of biopolymeric complex coacervation core micelles for efficient tea polyphenol delivery via a green process. Langmuir, 28, 14553-14561.
140. Zhu, K., Ye, T., Liu, J., Peng, Z., Xu, S., Lei, J., et al. (2013). Nanogels fabricated by lysozyme and sodium carboxymethyl cellulose for 5-fluorouracil controlled release. International Journal of Pharmaceutics, 41(1-2), 721-727.
141. Zou, T., and Gu, L. (2013). TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: In vitro characteristics and in vivo performance. Molecular Pharmaceutics, 10, 2062-2070.
142. Zou, T., Li, Z., Percival, S. S., Bonard, S., and Gu, L. (2012). Fabrication, characterization, and cytotoxicity evaluation of cranberry procyanidins-zein nanoparticles. Food Hydrocolloids, 27, 293-300.
143. Zou, T., Percival, S. S., Cheng, Q., Li, Z., Rowe, C. A., and Gu, L. (2012). Preparation, characterization, and induction of cell apoptosis of cocoa procyanidins-gelatin-chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 82, 36-42.
144. Zu, Y., Meng, L., Zhao, X., Ge, Y., Yu, X., Zhang, Y., et al. (2013). Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. International Journal of Nanomedicine, 8, 1207-1222.
145. Zu, Y., Zhang, Y., Zhao, X., Zhang, Q., Liu, Y., and Jiang, R. (2009). Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM). International Journal of Nanomedicine, 4, 321-333.